Members |
targetComponentId |
amylas 66 400 enheter + lipas 20 000 enheter + proteas 75 000 enheter, kapsel |
Amylase 66400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule |
amylas 66 400 enheter + lipas 20 000 enheter + proteas 75 000 enheter, kapsel |
Amylase 664400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule |
amylas 12 500 enheter + pankreaslipas 1 000 enheter + pankreasproteas 12 500 enheter, tablett |
Amylase 12500 unit and endopeptidase 12500 unit and triacylglycerol lipase 1000 unit oral tablet |
amylas 65 000 enheter + pankreaslipas 20 000 enheter + pankreasproteas 65 000 enheter, kapsel |
Amylase 65000 unit and endopeptidase 65000 unit and triacylglycerol lipase 20000 unit oral capsule |
biverkning av amobarbitalnatrium |
Amylobarbitone adverse reaction |
amobarbitalnatriumallergi |
Allergy to amobarbital (finding) |
familjär amyloidos med polyneuropati |
Wild type ATTR amyloidosis (disorder) |
AMC (arthrogryposis multiplex congenita) |
Congenital amyoplasia (disorder) |
Anaemia unspecified |
Anemia |
Anaerococcus tretradius |
Anaerococcus tetradius (organism) |
Anaesthetic or analgesic |
Medicinal product acting as analgesic agent (product) |
Anaesthetics and medical gases |
Medicinal product acting as anesthetic agent (product) |
anakinra 100 mg, injektionsvätska, lösning, förfylld spruta 0,67 ml |
Product containing precisely anakinra 149 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Anakinra 100mg/0.67mL injection prefilled syringe |
Product containing precisely anakinra 149 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Anakinra 100mg/mL injection solution 1mL prefilled syringe |
Product containing precisely anakinra 149 milligram/1 milliliter conventional release solution for injection (clinical drug) |
fynd som rör TNM-stadium hos tumör i analkanalen |
American Joint Committee on Cancer allowable value |
anafylaktisk reaktion orsakad av substans |
Anaphylaxis |
Anaplasma phagocytophila |
Anaplasma phagocytophilum (organism) |
Anastomosis of organ NOC |
Construction of anastomosis |
Anastomosis of pancreas |
Anastomosis of pancreatic duct |
anläggande av anastomos mellan magsäck och tolvfingertarm |
Anastomosis of stomach |
Anatomic pathology procedure or service |
Anatomic pathology procedure |
Anatomical concepts |
Physical anatomical entity |
Anatomical concepts |
Physical anatomical entity |
ansjovis, livsmedel |
Anchovy (substance) |
frakturtyp enligt Anderson-D'Alonzo |
Fracture configurations |
frakturtyp 2 enligt Anderson-D'Alonzo |
Anderson and D'Alonso type II fracture |
frakturtyp 3 enligt Anderson-D'Alonzo |
Anderson and D'Alonso type III fracture |
androblastom |
Androblastoma of uncertain behavior (morphologic abnormality) |
Androstanedione |
Androstenedione |
Androstenolone |
Dehydroepiandrosterone |
anemi orsakad av substans |
Anemia |
Anemia due to chemical agent |
Anemia |
Anemia of chronic disorder, NOS |
Anemia |
Anemia unspecified |
Anemia |
Anesthetic gas |
Gaseous dose form |
Angina decubitus NOS |
Angina decubitus |
egenvårdsplan vid angina |
Angina self management plan |
angioblastiskt meningiom |
Hemangioblastic meningioma |
Angiocentric T-cell lymphoma |
Extranodal NK/T-cell lymphoma, nasal type |
Angiocentric T-cell lymphoma |
Extranodal NK/T-cell lymphoma, nasal type |
Angiocentric T-cell lymphoma |
Natural killer-/T-cell lymphoma, nasal and nasal-type (morphologic abnormality) |
Angioendotheliomatosis |
Intravascular large B-cell lymphoma (disorder) |
angioendoteliomatos |
Intravascular large B-cell lymphoma (disorder) |
angiofibrom |
Angiofibroma (morphologic abnormality) |
Angioimmunoblastic lymphadenopathy with dysproteinemia |
Angioimmunoblastic T-cell lymphoma (disorder) |
Angioplasty - action |
Dilation - action |
ACE-hämmarallergi |
Non-allergic hypersensitivity to angiotensin-converting enzyme inhibitor |
gränsfall för trångvinkelglaukom |
Angle closure glaucoma suspect (disorder) |
Anhydrohydroxy progesterone preparation |
Product containing ethisterone (medicinal product) |
anidulafungin 100 mg, pulver till injektionsvätska, lösning, injektionsflaska |
Product containing only anidulafungin (medicinal product) |
Animal ear washing |
Irrigation of ear |
anjon |
Electrolyte anion (substance) |
Anisocytosis of red cells (morphologic abnormality) |
Anisocytosis, red cells (finding) |
ankel/arm-index-behandlingsplan |
Ankle brachial pressure index management plan (record artifact) |
somatisk dysfunktion i fotled |
Somatic dysfunction of ankle region (finding) |
Ankylosing vertebral hyperostosis |
Disseminated idiopathic skeletal hyperostosis |
Annual |
Annual |
Annuloplasty - action |
Reconstruction - action |
ASRT-testet (Anomalous sentence repetition test - Weeks) |
Anomalous sentences repetition test |
Anosmic aphasia |
Anomic aphasia |
Anser caerulescens |
Chen caerulescens (organism) |
Anser caerulescens caerulescens |
Chen caerulescens caerulescens (organism) |
överdos av disulfiram |
Disulfiram overdose (disorder) |
förgiftning orsakad av disulfiram |
Disulfiram poisoning (disorder) |
Antazoline sulfate+xylometazoline hydrochloride |
Product containing antazoline and xylometazoline (medicinal product) |
fasciokutan lambå från området runt armbågsvecket |
Fasciocutaneous flap |
lambå från området runt armbågsvecket |
Flap (substance) |
prenatal anti-D-profylax avböjd |
Administration of human anti-D immunoglobulin declined |
Antenatal blood group screening NOS |
Antenatal blood group screening status |
Antenatal blood group screening NOS |
Antenatal blood group screening status |
mödravård: kvinna med habituell abortbenägenhet |
Recurrent miscarriage |
prenatal korionvillibiopsi avböjd |
Sampling of chorionic villus declined |
prenatal blodscreening avseende hepatit B avböjd |
Antenatal screening for viral hepatitis type B declined |
prenatal blodscreening avseende HIV avböjd |
Antenatal screening for human immunodeficiency virus declined (situation) |
Antenatal scan unable to confirm pregnancy |
Antenatal scan unable to confirm pregnancy (finding) |
prenatal blodscreening avseende talassemi avböjd |
Antenatal thalassemia screening declined (situation) |
Antenatal ultrasound confirms ectopic pregnancy |
Antenatal ultrasound confirms ectopic pregnancy (finding) |
Antenatal ultrasound confirms intrauterine pregnancy |
Antenatal ultrasound confirms intrauterine pregnancy (finding) |
Antepartum haemorrhage NOS |
Antepartum hemorrhage |
Antepartum haemorrhage NOS |
Antepartum hemorrhage |
Antepartum hemorrhage NOS |
Antepartum hemorrhage |
blödning ante partum orsakad av disseminerad intravasal koagulation |
Antepartum hemorrhage with disseminated intravascular coagulation (disorder) |
Anterior cervical cord injury, without bony injury, C1-4 |
Anterior cervical spinal cord injury at C1-C4 level without spinal bone injury |
Anterior cervical cord injury, without bony injury, C5-7 |
Anterior cervical spinal cord injury, without spinal bone injury, C5-7 (disorder) |
främre cervikal lambå |
Flap (substance) |
främre bröstkorgslambå |
Flap (substance) |
främre lårlambå |
Flap (substance) |
Anterior tibial fasciocutaneous flap |
Anterior tibial artery fasciocutaneous flap (substance) |
främre tibialambå |
Anterior tibial artery flap (substance) |
Antheorfilter för temporärt bruk |
Temporary vena cava filter |
antralin 0,2 %, kräm |
Product containing only dithranol in cutaneous dose form (medicinal product form) |
antralin 0,2 %, hudkräm |
Product containing only dithranol in cutaneous dose form (medicinal product form) |
antralin 0,4 %, kräm |
Product containing only dithranol in cutaneous dose form (medicinal product form) |
antralin 0,4 %, hudkräm |
Product containing only dithranol in cutaneous dose form (medicinal product form) |
färg innehållande antrakinon |
Anthraquinone |
immunglobulin anti-D (Rh) 1 250 IE/ml, injektionsvätska, lösning, förfyllld spruta 1 ml |
Human anti-D immunoglobulin 1250 unit/mL solution for injection |
biverkning av immunglobulin anti-D (Rh) |
Human anti-D immunoglobulin adverse reaction (disorder) |
Anti-D globulin NOS |
Administration of human anti-D immunoglobulin (procedure) |
Anti-D globulin NOS |
Administration of human anti-D immunoglobulin (procedure) |
Anti-D globulin given |
Human anti-D immunoglobulin administered (situation) |